Figures and Tables

From the following article:

Transforming growth factor beta as a therapeutic target in systemic sclerosis

John Varga & Boris Pasche

Nature Reviews Rheumatology 5, 200-206 (April 2009)

doi:10.1038/nrrheum.2009.26

Figure 1 - Transforming growth factor |[beta]| as a therapeutic target in systemic sclerosis

Figure 1

Major components of the TGF-beta signaling pathway.

Figure 2 - Transforming growth factor |[beta]| as a therapeutic target in systemic sclerosis

Figure 2

Strategies for blocking TGF-beta pathways.

Table 1 - Transforming growth factor |[beta]| as a therapeutic target in systemic sclerosis

Table 1

Proposed therapeutic strategies for blocking the TGF-beta pathway

Table 2 - Transforming growth factor |[beta]| as a therapeutic target in systemic sclerosis

Table 2

Currently used drugs with anti-TGF-beta activity